A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response ...

There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for patients with stage 3 or 4 kidney cancer, who face high recurrence risk.

Scientists at Sanaria and Seattle Children's Research Institute's Center for Global Infectious Disease Research (CGIDR) have unveiled a groundbreaking malaria vaccine, Sanaria® PfSPZ-LARC2 Vaccine, ...

Terrain Biosciences launches from stealth today as the world's first RNA design-build company, using advanced AI and its ...

In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...

A New Hope? Russia has developed a therapeutic cancer vaccine, which means it won’t prevent cancer but aims to cure it.

That’s thanks to a major philanthropic commitment from Sarasota’s Brian and Sheila Jellison Family Foundation. As the first ...

However, analysts project potential upside of 92% in 2025, according to the Street-high estimate.  Investors should also note that Merck pays a dividend yielding 3.71%, more than twice the healthcare ...

We recently compiled a list of the These 10 Firms Were Last Week’s Worst Performers. In this article, we are going to take a ...

A musician who made global news as one of the first people to receive a skin cancer vaccine has held a sell-out concert to thank those who helped him. Steve Young, from Stevenage, Hertfordshire, ...

Left to right - Dr. Riccardo Rampado & Prof. Dan Peer. Researchers at Tel Aviv University have achieved a breakthrough in ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other ...